Michael Scordo

19PUBLICATIONS
180CO-AUTHORS
Predictive and prognostic markersMedical bacteriologyRadiation therapyCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 31, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Feb 24, 2026
Respiratory Syncytial Virus After Chimeric Antigen Receptor T-cell Therapy: Risk Factors and Outcomes in a Multicenter Retrospective Cohort.

Maria Isabel Sotelo-Alva, Ofrat Beyar-Katz, Judy Yan

|Dec 04, 2025
A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.

Urvi A Shah, Laura Lucia Cogrossi, Juan-Jose Garcés

|Sep 16, 2025
Defining the Rates of Cytokine Release Syndrome Associated With Talquetamab Step-up Doses.

Issam S Hamadeh, Lisa Modelevsky, Amelia Chan

|Aug 25, 2025
Immune MRD Status Informs Tumor MRD Outcome Prognostication in Patients with Multiple Myeloma on Lenalidomide Maintenance.

Ross S Firestone, Anish K Simhal, Devin McAvoy

Pageof 4

Frequent Collaborators

12 joint publications

Gunjan Shah

8 joint publications

Sergio Giralt

6 joint publications

Heather Landau

6 joint publications

Urvi A Shah